{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:29:35Z","timestamp":1777858175700,"version":"3.51.4"},"reference-count":32,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Feline Medicine and Surgery Open Reports"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Case summary<\/jats:title>\n                    <jats:p>A 19-year-old, spayed female domestic shorthair cat was referred with diabetes mellitus and difficulties in achieving glycemic control. Hypersomatotropism (HST) was diagnosed based on clinical signs compatible with acromegaly (prognathia inferior, broad facial features and abdominal enlargement), increased serum insulin-like growth factor 1 (IGF-1) concentration (4430\u2009ng\/ml) and pituitary enlargement (height 4.7\u2009mm). Serum IGF-1 concentrations, biochemical analysis and urinalysis were performed at the time of HST diagnosis and after 10, 20, 30, 60, 120 and 180 days of pegvisomant treatment (PEGV, Somarvet; Pfizer). The cat received PEGV (1\u2009mg\/kg SC q24h) in combination with cabergoline (10\u2009\u03bcg\/kg PO q48h). Serum IGF-1 concentrations decreased abruptly to 396\u2009ng\/ml on day 10 of PEGV treatment and blood glucose concentrations also decreased rapidly. Insulin was no longer required after 7 days of PEGV. From day 30 (IGF-1 286\u2009ng\/ml), PEGV was administered q48h and the same therapeutic response was maintained after 60 days of treatment (IGF-1 290\u2009ng\/ml and diabetic remission). From day 120, PEGV was administered once weekly and normal IGF-1 concentrations (270\u2009ng\/ml) were observed after 180 days of treatment. The cat also showed improvements in echocardiographic variables and in her quality of life (QoL) score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Relevance and novel information<\/jats:title>\n                    <jats:p>This is the first reported case of PEGV plus cabergoline treatment in a cat with HST. The results suggest that the combined treatment of PEGV and cabergoline was associated with normalization of IGF-1 concentrations, diabetic remission, and improvement of cardiovascular function and QoL over a short period.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/20551169261427069","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:46:01Z","timestamp":1771328761000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Combined treatment of pegvisomant and cabergoline in a cat with hypersomatotropism: insulin-like growth factor 1 normalization and control of comorbidities"],"prefix":"10.1177","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2271-2741","authenticated-orcid":false,"given":"Diego D","family":"Miceli","sequence":"first","affiliation":[{"name":"Veterinary Science Center, Maimonides University, Buenos Aires, Argentina"},{"name":"Laboratory of Molecular Endocrinology and Signal Transduction, Institute of Experimental Biology and Medicine \u2013 CONICET, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6924-0318","authenticated-orcid":false,"given":"Juan P","family":"Rey Amunategui","sequence":"additional","affiliation":[{"name":"Faculty of Veterinary Sciences, University of Buenos Aires, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo A","family":"Pompili","sequence":"additional","affiliation":[{"name":"Faculty of Veterinary Sciences, University of Buenos Aires, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"M\u00e1s","sequence":"additional","affiliation":[{"name":"Diagnotest Laboratory, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar P","family":"Pignataro","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Endocrinology and Signal Transduction, Institute of Experimental Biology and Medicine \u2013 CONICET, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirtha","family":"Guitelman","sequence":"additional","affiliation":[{"name":"Endocrinology Unit, Carlos G Durand Hospital, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cvsm.2009.10.007"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1660021"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127794"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/1098612X221074924"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1177\/1098612X221098718"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1096-6374(03)00076-5"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1210\/js.2018-00226"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/1098612X221148565"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.domaniend.2024.106858"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.domaniend.2024.106898"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200004203421604"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06844-1"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02112"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0239"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.4158\/EP14330.OR"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2014.21"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0500"},{"key":"e_1_3_2_19_2","first-page":"328","article-title":"Brazilian multicenter study on pegvisomant treatment in acromegaly.","volume":"63","author":"Boguszewski CL","year":"2019","unstructured":"Boguszewski CL, Huayllas MKP, Vilar L, et al. Brazilian multicenter study on pegvisomant treatment in acromegaly. Arch Endocrinol Metab 2019; 63: 328\u2013336.","journal-title":"Arch Endocrinol Metab"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvjl.2022.105910"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/jvim.16047"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2008.0242.x"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/jvim.14662"},{"key":"e_1_3_2_24_2","article-title":"Diabetes mellitus remission in three cats with hypersomatotropism after cabergoline treatment.","volume":"7","author":"Miceli DD","year":"2021","unstructured":"Miceli DD, Vidal PN, Pompili GA, et al. Diabetes mellitus remission in three cats with hypersomatotropism after cabergoline treatment. JFMS Open Rep 2021; 7: Article 20551169211018991.","journal-title":"JFMS Open Rep"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2013.09.004"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2001-0022"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2011.03.004"},{"key":"e_1_3_2_28_2","article-title":"Spectrum of veterinary care in feline diabetes mellitus.","volume":"18","author":"Rand J","year":"2025","unstructured":"Rand J, Mott J, Kendall K, et al. Spectrum of veterinary care in feline diabetes mellitus. J Feline Med Surg 2025; 18: Article 1098612X251401500.","journal-title":"J Feline Med Surg"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-012-0382-z"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-018-0231-9"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0194342"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-007-0062-6"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03346562"}],"container-title":["Journal of Feline Medicine and Surgery Open Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20551169261427069","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20551169261427069","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20551169261427069","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:08:58Z","timestamp":1777507738000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20551169261427069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1177\/20551169261427069"],"URL":"https:\/\/doi.org\/10.1177\/20551169261427069","relation":{},"ISSN":["2055-1169","2055-1169"],"issn-type":[{"value":"2055-1169","type":"print"},{"value":"2055-1169","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"article-number":"20551169261427069"}}